Redcare Pharmacy N.V.

General ticker "SHPPF" information:

  • Sector: Health Care
  • Industry: Medical - Pharmaceuticals
  • Capitalization: $2.1B (TTM average)

Redcare Pharmacy N.V. does not follow the US Stock Market performance with the rate: -40.6%.

Estimated limits based on current volatility of 7.4%: low 45.14$, high 52.35$

Factors to consider:

  • Price in estimated range
  • Earnings for 3 months up through Q1 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

  • 2025-12-31 to 2026-12-31 estimated range: [30.73$, 83.72$]
  • 2026-12-31 to 2027-12-31 estimated range: [20.86$, 56.30$]

Similar symbols

Short-term SHPPF quotes

Long-term SHPPF plot with estimates

Financial data

YTD 2023-12-31 2024-12-31 2025-12-31
Operating Revenue €1,798.76MM €2,370.57MM €2,939.80MM
Operating Expenses €1,816.05MM €2,409.56MM €2,963.59MM
Operating Income €-17.30MM €-38.99MM €-23.79MM
Non-Operating Income €2.95MM €-8.85MM €-23.89MM
Interest Expense €8.00MM €7.78MM €20.29MM
Income(Loss) €-14.35MM €-47.83MM €-47.68MM
Taxes €2.74MM €-1.48MM €-8.30MM
Profit(Loss)* €-12.04MM €-45.46MM €-37.69MM
Stockholders Equity €522.19MM €483.98MM €459.03MM
Inventory €135.79MM €153.82MM €213.92MM
Assets €1,021.60MM €1,003.28MM €1,246.03MM
Operating Cash Flow €61.46MM €22.13MM €22.99MM
Capital expenditure €38.22MM €42.15MM €79.27MM
Investing Cash Flow €-59.96MM €8.38MM €-151.34MM
Financing Cash Flow €15.05MM €-17.94MM €124.05MM
Earnings Per Share** €-0.63 €-2.26 €-1.87

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.